Rilutek is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Covis Pharma. The primary component is Riluzole.
| Product ID | 70515-700_6ddc26d7-a6fe-46dd-8b49-c55aa111f83e |
| NDC | 70515-700 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rilutek |
| Generic Name | Riluzole |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020599 |
| Labeler Name | Covis Pharma |
| Substance Name | RILUZOLE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Benzothiazole [EPC],Benzothiazoles [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020599 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-08-01 |
| Ingredient | Strength |
|---|---|
| RILUZOLE | 50 mg/1 |
| SPL SET ID: | 6ddc26d7-a6fe-46dd-8b49-c55aa111f83e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70515-700 | Rilutek | riluzole |
| 10094-350 | EXSERVAN | riluzole |
| 70510-2201 | Exservan | riluzole |
| 70510-2202 | Exservan | riluzole |
| 0378-4145 | Riluzole | riluzole |
| 42291-775 | Riluzole | riluzole |
| 60505-3285 | RILUZOLE | RILUZOLE |
| 62756-538 | Riluzole | Riluzole |
| 64980-191 | Riluzole | riluzole |
| 67877-286 | Riluzole | Riluzole |
| 68084-908 | RILUZOLE | RILUZOLE |
| 68462-381 | riluzole | riluzole |
| 69076-200 | Riluzole | riluzole |
| 69076-611 | Riluzole | Riluzole |
| 70726-0303 | TIGLUTIK | Riluzole |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RILUTEK 74451450 1866694 Live/Registered |
COVIS PHARMA B.V. 1993-10-26 |